Name

ILDONG Bioscience

Legal name

ILDONG Bioscience Co., Ltd.

Website

https://ildongbio.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Probiotic Ingredients

NAICS

Food Manufacturing (311)

SIC

Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Probiotic ingredients
• Postbiotic manufacturing
• Strain CDMO services
• Dietary supplement ingredients
• Functional food ingredients

Headquarters

HQ city

Do Kraloveho

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Probiotic Raw Material and Ingredient Supply: Supplying probiotic materials and ingredients (including over 20 GRAS-recognized ingredients) to manufacturers of functional foods, beverages, dietary supplements, and animal nutrition products globally.
2. OEM & ODM Manufacturing Services: Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) services for finished probiotic products, including supply of raw materials combined with product design and manufacturing capabilities. ODM products have achieved top-seller status in Thailand's probiotics category.
3. Functional Ingredient Licensing: Licensing of proprietary strains (IDCC series) and technologies (Q-Shield coating) as functional food ingredients to partners in target markets, with regulatory support for US GRAS, Thai FDA, and other regional approvals.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

ILDONG Bioscience supplies probiotic, postbiotic, and parabiotic raw materials, ingredients, and finished products to B2B customers worldwide. The company leverages its proprietary Q-Shield® quadruple-coating technology and proprietary IDCC strain library to deliver clinically validated, multi-certified (US GRAS, Non-GMO Project, Halal, Kosher, KFDA, Thai FDA) functional ingredients to functional food, dietary supplement, animal nutrition, cosmetic, and pet nutrition manufacturers. It also offers OEM/ODM and strain CDMO services for turnkey product development.

Product overview

ILDONG Bioscience is a Korean probiotic ingredients company offering a comprehensive portfolio of functional ingredients and health solutions built on 80 years of fermentation expertise. The core offering centers on Q-Shield® quadruple-coating technology that protects probiotic strains through the digestive system. The product range includes branded probiotic strains such as SPORABLE® (Bacillus coagulans IDCC 1201) for sleep health, BBR4401® for cholesterol management, RHT3201® for immune and skin health, and B. lactis Fit™ (IDCC 4301) for weight management. The company also offers postbiotics and parabiotics including tyndallized strains for topical applications, cosmetics (Cera-Glow®), inner beauty supplements (Post-Collagen®), and contract development/manufacturing services. Products are marketed to functional foods, dietary supplements, animal nutrition, cosmetics, and pet nutrition industries globally.

Differentiator

Problem solved

Functional benefit

Brands

• Q-Shield: Proprietary quadruple-coating technology for probiotic protection and enhanced survival through the digestive system.
• SPORABLE
• Ceraglow
• Post-Collagen
• B.lactis Fit

Products and services

• Q-Shield® (Quadruple-Coated Probiotics) Proprietary 4-layer coating technology that protects probiotic bacteria from stomach acid, bile salts, heat, and moisture during digestive transit, improving intestinal adhesion up to 10.8-fold and pathogen exclusion up to 4.3-fold. Sold as a proprietary coating technology applied across ILDONG's probiotic ingredient offerings for functional food, supplement, and animal nutrition manufacturers.
• SPORABLE® (Bacillus coagulans IDCC 1201) Spore-forming probiotic strain with inherent resistance to extreme temperature and pH, marketed for sleep and stress health applications via GABA-producing capabilities. Sold to supplement manufacturers as a branded functional ingredient.
• BBR4401® Postbiotic product targeting LDL cholesterol reduction through enhanced bile acid synthesis and physiochemical interaction with cholesterol molecules. Sold to supplement manufacturers as a branded functional ingredient.
• RHT3201® Postbiotic developed from a non-viable form of an L. rhamnosus-like probiotic strain, approved by Korean KFDA and Thai FDA for immune health and skin immunity applications, including atopic dermatitis management. Sold to functional food and supplement manufacturers.
• B. lactis Fit™ (Bifidobacterium lactis IDCC 4301) Bifidobacterium lactis probiotic strain with clinical evidence for weight management, body fat reduction, gut-lung axis support, and cardiometabolic health. Sold to supplement manufacturers as a branded functional ingredient.
• L. casei IDCC 3451 (Psychobiotic) Psychobiotic Lactobacillus casei strain targeting the gut-brain axis, with demonstrated effects on amyloid beta accumulation, stress response, and mental wellness. Sold to supplement manufacturers targeting mental wellness applications.
• Tyndallized Lactobacillus acidophilus IDCC 3302 (ACT3302) Heat-killed (tyndallized) Lactobacillus acidophilus parabiotic for topical skin care applications, providing protection against UVB-induced skin damage and enhancement of skin barrier function. Sold to cosmetics and skincare manufacturers.
• Cera-Glow® Cosmetic skincare product line derived from probiotic essence, offering topical skin protection and rejuvenation solutions. Sold to cosmetics brand manufacturers for incorporation into dermocosmetic products.
• Post-Collagen® Inner beauty supplement product line combining collagen and probiotics for skin health from within. Sold to supplement and functional food manufacturers targeting beauty-from-within applications.
• Probiotic and Omega-3 Combination Formulation Combined probiotic and omega-3 fatty acid formulation pioneered in Korea, leveraging synergistic benefits for gut health and anti-inflammatory effects. Maintained over 95% viability after 12 months of storage at room temperature. Sold to supplement and functional food manufacturers.
• Strain CDMO Services Contract Development and Manufacturing Organization (CDMO) services for probiotic strain development, offering fully customized probiotic solutions for human digestive health and targeted therapeutic outcomes. Leverages ILDONG's strain library, coating technology, fermentation infrastructure, and regulatory expertise.
• OEM and ODM Services Original Design Manufacturing (ODM) and Original Equipment Manufacturing (OEM) services for finished probiotic products, including supply of raw materials combined with product design and manufacturing capabilities. ODM products have achieved top-seller status in Thailand's probiotics category. Product formats include capsules, tablets, powders, sachets, and gummies.
• Probiotic Ingredient Portfolio Core portfolio of probiotic raw materials and ingredients, including various Lactobacillus and Bifidobacterium strains from the IDCC proprietary strain library, supplied to functional food, supplement, pet nutrition, and animal nutrition manufacturers globally.
• Post and Parabiotic Ingredient Portfolio Portfolio of non-viable microbial by-products (postbiotics) and inactivated microbial cells (parabiotics) offering health benefits including immune modulation, anti-inflammatory properties, and broader formulation flexibility. Sold to functional food, supplement, and cosmetic manufacturers.

Quantifiable outcome

• Q-Shield coating increased intestinal adhesion power up to 10.8-fold in Lactobacillus fermentum IDCC 3901 and Lactobacillus salivarius IDCC 3551 strains
• +9 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core, flagship and minor.

• NutralliancecoreChannel Partner/ Reseller/ DistributorNutralliance serves as the exclusive distributor for ILDONG Bioscience probiotic ingredients in the United States. The partnership encompasses regulatory navigation support (FDA GRAS, NDI notifications), sales representation at US trade events (Florida Section Suppliers' Night Expo), and customer relationship management for US-based manufacturers and supplement brands.
• ILDONG Pharmaceutical (Parent Company)flagshipStrategic or Co-development PartnerILDONG Bioscience was established in 2016 as a corporate spin-off from ILDONG Pharmaceutical, inheriting its parent's core technology, infrastructure, and 80+ years of probiotic research expertise. The company bases its operations on ILDONG Pharmaceutical's fermentation technology and microbiome science capabilities, continuing joint development of functional materials using probiotics.
• Seoul National University Bundang HospitalminorStrategic or Co-development PartnerProfessor Na-Young Kim's team from Seoul National University Bundang Hospital's Department of Gastroenterology collaborated on research demonstrating that butyrate-producing probiotics (Clostridium butyricum IDCC 1301) can restore gut health disrupted by high-fat diets. Study findings published in Digestive Diseases and Sciences and Journal of Neurogastroenterology and Motility.
• NutralliancecoreGTM or Marketing PartnerNutralliance serves as the exclusive US distributor and marketing representative, showcasing ILDONG Bioscience ingredients at trade events and providing market access, sales support, and regulatory expertise to facilitate entry of ILDONG probiotic strains into the US dietary supplements and functional foods market.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Novonesis (formerly Chr. Hansen): Global B2B supplier of microbial and fermentation-based ingredients, including a leading portfolio of probiotic strains for supplements, dairy, and infant nutrition. Directly comparable to ILDONG Bioscience in serving functional food and supplement brands with clinically documented, regulatory-cleared probiotic ingredients.
• BioGaia: Swedish probiotic specialist focused on clinically validated Lactobacillus reuteri strains for gut health, immune, and oral health, with a global B2B and licensing model. Comparable to ILDONG Bioscience as a science-led, clinically validated probiotic ingredient supplier with strong IP and trademarked strain portfolios.
• Sabinsa: US-headquartered ingredient manufacturer specializing in clinically validated nutraceutical and probiotic ingredients, supplying supplement brands globally. Comparable to ILDONG Bioscience as a science-driven B2B ingredient supplier with branded, clinically substantiated probiotics and postbiotics in a global sales model.
• Lallemand Health Solutions: Canadian-based probiotic and yeast manufacturer with proprietary strains and documented health claims, supplying nutraceutical and functional food brands worldwide. Comparable to ILDONG Bioscience as a vertically integrated fermentation-to-ingredient supplier with multiple proprietary strains and clinical evidence.
• Gnosis by Lesaffre: Italian-headquartered microbial fermentation specialist producing probiotic, yeast, and postbiotic ingredients for the human nutrition, pharma, and animal nutrition markets. Closely comparable to ILDONG Bioscience given its postbiotic offering (Lesaffre has been a postbiotics leader) and B2B ingredient model spanning human and animal nutrition.
• Probi AB: Swedish-listed B2B probiotic ingredient supplier with documented strains for gut, immune, and metabolic health, supplying supplement and functional food manufacturers globally. Directly comparable in business model (B2B probiotic ingredient supplier) and clinical evidence strategy to ILDONG Bioscience.

Broad incumbents

• Morinaga Milk Industry: Japanese dairy and functional ingredient company with proprietary probiotic strains (notably Bifidobacterium longum BB536) and a broad portfolio of B2B ingredients across food, supplements, and infant nutrition. Comparable to ILDONG Bioscience in strain-level science and Asia-led commercialization, though significantly larger and more diversified.
• Yakult Honsha: Japanese probiotics pioneer with Lactobacillus casei Shirota and a global consumer brand plus B2B ingredient/supply arm. Comparable to ILDONG Bioscience in probiotic category leadership, although primarily a brand-led consumer model with significantly larger scale.
• ADM (Biopolis / probiotic ingredient business): Global agricultural and nutrition major with a probiotic and microbiome ingredient business (built on the Biopolis acquisition) supplying supplement and functional food manufacturers. Comparable to ILDONG Bioscience as a B2B probiotic ingredient supplier, but operating at vastly greater scale and broader category breadth.

Emerging players

• AB Biotics (Kaneka): Spanish probiotic ingredient company (acquired by Japan's Kaneka) focused on proprietary strains for gut and women's health, supplying supplement brands in Europe, Asia, and the Americas. Comparable to ILDONG Bioscience as a specialist B2B probiotic ingredient supplier with proprietary strain IP and global ambitions, though smaller and earlier in geographic expansion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ILDONGBIOSCIENCE
• LinkedInlinkedin.com/company/ildongbioscience

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ILDONG Bioscience